TRIP4 Exon 11 Deletion in 4 Related Patients: Expanding the Molecular Landscape of ASC-1 Complex–Related Neuromuscular Disease

Pathogenic variants in TRIP4 are a known cause of several congenital neuromuscular disorders, including spinal muscular atrophy with congenital bone fractures, congenital myopathy, and cerebellar hypoplasia with peripheral neuropathy. TRIP4 encodes a core component of the Activating Signal Cointegrator 1 (ASC-1) complex, but intragenic deletions affecting this gene have rarely been reported. Here, we describe 4 related individuals carrying a previously unreported homozygous deletion involving exon 11 of TRIP4 . Genetic testing was performed using next-generation sequencing, followed by confirmation with Sanger sequencing. Chromosomal microarray analysis independently confirmed the exon-level deletion and did not reveal additional pathogenic copy number variants. The same deletion was identified in all affected family members. Clinically, patients showed variable neuromuscular involvement within the same pedigree. In addition to neuromuscular involvement, affected individuals exhibited neurodevelopmental features, including delayed speech development, learning difficulties, and seizures, further expanding the clinical spectrum associated with TRIP4 deficiency. This variability is consistent with the broad phenotypic spectrum previously associated with ASC-1 complex dysfunction. To our knowledge, comparable familial cases with a homozygous TRIP4 exon 11 deletion have not been reported. The exon 11 deletion is likely to affect TRIP4 protein function and may influence transcriptional regulation during muscle development. Our findings add a new type of TRIP4 alteration to the existing literature and support the routine evaluation of copy number variants alongside sequencing-based approaches when investigating rare congenital neuromuscular disorders. This finding supports a role for TRIP4 and the ASC-1 complex in neuromuscular development.

Authors

Institutions

Publication Details

Journal
Journal of Child Neurology
Published
2026-11-20
DOI
https://doi.org/10.1177/08830738261510104
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

TRIP4 Exon 11 Deletion in 4 Related Patients: Expanding the Molecular Landscape of ASC-1 Complex–Related Neuromuscular Disease

Rohat Oztepeli, Murat Öztürk, Cahide Bulut Arslan
Journal of Child Neurology
Genomics and Rare Diseases
article

TRIP4 Exon 11 Deletion in 4 Related Patients: Expanding the Molecular Landscape of ASC-1 Complex–Related Neuromuscular Disease

Rohat Oztepeli, Murat Öztürk, Cahide Bulut Arslan
article en

Abstract

Pathogenic variants in TRIP4 are a known cause of several congenital neuromuscular disorders, including spinal muscular atrophy with congenital bone fractures, congenital myopathy, and cerebellar hypoplasia with peripheral neuropathy. TRIP4 encodes a core component of the Activating Signal Cointegrator 1 (ASC-1) complex, but intragenic deletions affecting this gene have rarely been reported. Here, we describe 4 related individuals carrying a previously unreported homozygous deletion involving exon 11 of TRIP4 . Genetic testing was performed using next-generation sequencing, followed by confirmation with Sanger sequencing. Chromosomal microarray analysis independently confirmed the exon-level deletion and did not reveal additional pathogenic copy number variants. The same deletion was identified in all affected family members. Clinically, patients showed variable neuromuscular involvement within the same pedigree. In addition to neuromuscular involvement, affected individuals exhibited neurodevelopmental features, including delayed speech development, learning difficulties, and seizures, further expanding the clinical spectrum associated with TRIP4 deficiency. This variability is consistent with the broad phenotypic spectrum previously associated with ASC-1 complex dysfunction. To our knowledge, comparable familial cases with a homozygous TRIP4 exon 11 deletion have not been reported. The exon 11 deletion is likely to affect TRIP4 protein function and may influence transcriptional regulation during muscle development. Our findings add a new type of TRIP4 alteration to the existing literature and support the routine evaluation of copy number variants alongside sequencing-based approaches when investigating rare congenital neuromuscular disorders. This finding supports a role for TRIP4 and the ASC-1 complex in neuromuscular development.

Journal of Child Neurology
Ministry of Health (TR), Batman University (TR)
Good health and well-being
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon